These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33633982)

  • 1. The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancer.
    You C; Xiao Q; Zhu X; Sun Y; Di G; Liu G; Hou Y; Chen C; Wu J; Shao Z; Gu Y; Hu Z
    Gland Surg; 2021 Jan; 10(1):262-272. PubMed ID: 33633982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
    Ha SM; Chae EY; Cha JH; Kim HH; Shin HJ; Choi WJ
    AJR Am J Roentgenol; 2017 Oct; 209(4):920-928. PubMed ID: 28796549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation.
    Noh JM; Han BK; Choi DH; Rhee SJ; Cho EY; Huh SJ; Park W; Park H; Nam SJ; Lee JE; Kil WH
    J Breast Cancer; 2013 Sep; 16(3):308-14. PubMed ID: 24155760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.
    Kwong A; Wong LP; Wong HN; Law FB; Ng EK; Tang YH; Chan WK; Suen DT; Choi C; Ho LS; Kwan KH; Poon M; Wong TT; Chan K; Chan SW; Ying MW; Chan WC; Ma ES; Ford JM; West DW
    Hugo J; 2009 Dec; 3(1-4):63-76. PubMed ID: 20535403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
    Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
    Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
    Atchley DP; Albarracin CT; Lopez A; Valero V; Amos CI; Gonzalez-Angulo AM; Hortobagyi GN; Arun BK
    J Clin Oncol; 2008 Sep; 26(26):4282-8. PubMed ID: 18779615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
    Murakami W; Tozaki M; Nakamura S; Ide Y; Inuzuka M; Hirota Y; Murakami K; Takahama N; Ohgiya Y; Gokan T
    Breast Cancer; 2019 Sep; 26(5):552-561. PubMed ID: 30820924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
    Deb S; Jene N; ; Fox SB
    BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonographic features of breast carcinoma presenting as masses in BRCA gene mutation carriers.
    Mesurolle B; Kadoch L; El-Khoury M; Lisbona A; Dendukuri N; Foulkes WD
    J Ultrasound Med; 2007 Jun; 26(6):817-24. PubMed ID: 17526613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country.
    Yip CH; Taib NA; Choo WY; Rampal S; Thong MK; Teo SH
    World J Surg; 2009 Oct; 33(10):2077-81. PubMed ID: 19649760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
    Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
    Pellegrino B; Bella M; Michiara M; Zanelli P; Naldi N; Porzio R; Bortesi B; Boggiani D; Zanoni D; Camisa R; Neri TM; Pinto C; Musolino A
    Acta Biomed; 2016 May; 87(1):54-63. PubMed ID: 27163896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
    Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
    Pilewskie M; Zabor EC; Gilbert E; Stempel M; Petruolo O; Mangino D; Robson M; Jochelson MS
    Breast Cancer Res Treat; 2019 May; 175(1):141-148. PubMed ID: 30673971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.
    Atcı MM; Geredeli Ç; Ay S; Sakin A; Ertürk B; Seçmeler Ş; Arıcı S; Çekin R; Yaşar N; Can O; Cihan Ş; Gümüş M
    Eur J Breast Health; 2021 Apr; 17(2):123-127. PubMed ID: 33870111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Eleven Novel
    Hamdi Y; Mighri N; Boujemaa M; Mejri N; Ben Nasr S; Ben Rekaya M; Messaoud O; Bouaziz H; Berrazega Y; Rachdi H; Jaidane O; Daoud N; Zribi A; Ayari J; El Benna H; Labidi S; Ben Hassouna J; Haddaoui A; Rahal K; Benna F; Mrad R; Ben Ahmed S; Boussen H; Boubaker S; Abdelhak S
    Front Oncol; 2021; 11():674965. PubMed ID: 34490083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of clinicopathological features and chemotherapeutic outcomes in women with BRCA1 and BRCA2 mutation-negative familial breast cancer].
    Zhang J; Sun J; Ouyang T; Li JF; Wang TF; Fan ZQ; Fan T; Lin BY; Xie YT
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):185-9. PubMed ID: 26988823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.